News | 15 August 2012
Venture capital funding in biotechnology and medical device industries decreased 39 percent during the second quarter of 2012, according to a PricewaterhouseCoopers report, ?Dollar Drought.? The VC investment equaled $1.4 billion, the lowest level ...
Click on the link to read the full article at Colorado Springs Business Journal
(This link will open in a new window)